Explore the next generation of armed oncolytic immunotherapies in combination which have the greatest potential for clinical and commercial success.
The Armed Oncolytic Immunotherapy Summit is your opportunity to hear the most up-to-date clinical advances alongside novel therapeutic strategies to increase potency, targeting and immune cell recruitment, in the effort to turn cold tumours hot.
http://www.oncolytic-immunotherapies.com/
26-28 June, 2018
Contact:
This email address is being protected from spambots. You need JavaScript enabled to view it.
+44 (0)20 3141 8700
Category: Conferences | Science, Health and Medicine | Oncology
Prices:
Conference + 2 Workshops Earlybird (Book by 23/03/18): EUR 2197
Conference + 2 Workshops (standard rate): EUR 2597
Conference + 1 Workshop Earlybird (Book by 23/03/18): EUR 1798
Conference + 1 Workshop (standard rate): EUR 2198
Conference Earlybird (Book by 23/03/18): EUR 1399
Conference (Standard rate): EUR 1799
Workshop only: EUR 499
On Tuesday June 26, 2018 at 9:00 am (ends Thursday June 28, 2018 at 5:00 pm)
URLs:
Booking: https://go.evvnt.com/207531-0?pid=5569
Brochure: https://go.evvnt.com/207531-1?pid=5569
Speakers: Akseli Hemminki (TILT Biotherapeutics), Daniel Katzman (Unleash Immuno Oncolytics), Colin Love (Replimune), Gabriella Campadelli-Fiume (NousCom), Frank Tufaro (DNAtrix), Stephen Russell (Vyriad)
Venue details: Le Meridien Frankfurt, Wiesenhuettenplatz 28-38, Frankfurt, 60329, Germany